Epidermolysis Bullosa Congenita: Up-to-date View

Czech version

Authors: H. Bučková ¹; J. Buček ²; J. Vokurková ³
Authors‘ workplace: Kožní oddělení I. dětské interní kliniky LF MU a FN Brno přednosta prof. MUDr. Hana Hrstková, CSc. ¹; I. patologicko-anatomický ústav LF MU, Fakultní nemocnice U Svaté Anny, Brno přednosta prof. MUDr. Aleš Rejtar, CSc. ²; Klinika popálenin a rekonstrukční chirurgie LF MU a FN Brno přednosta prof. MUDr. Pavel Brychta, CSc. ³
Published in: Čes-slov Derm, 80, 2005, No. 4, p. 201-206
Category: Reviews (Continuing Medical Education)

Overview

The authors summarise the last knowledge of epidermolysis bullosa congenita (EB). The Centre for EB patients based on cooperation of the multidisciplinary group of specialists has been founded by The Department of Paediatric Dermatology in Brno. In the last ten years the center diagnosed 87 EB patients (DEB 46%, SEB 44%, JEB 10%). In May 2004 the DebRA (Dystrophic Epidermolysis Bullosa Research Association) ČR (www.debra-cz.org) has been founded. DebRA Czech Republic is a member of DebRA International.

Key words:
classification – pathogenesis – clinical picture – squamous cell carcinoma – DebRA Czech Republic - gene therapy

Labels

Dermatology & STDs Paediatric dermatology & STDs

Bacterial Antigens in the Pathogenesis of Atopic Dermatitis

Experience of Paediatric Venereology Out-patient Clinic of The University Hospital in Brno in Congenital Syphilis

A New Look on the Vascular Anomalies in Children

Comparative Study of Acne Treatment with Vaccines and Systemic Antibiotics. 1. Evaluation of Therapeutic Effect

Article was published in

Czech-Slovak Dermatology

2005 Issue 4